Breast Cancer Screening Sector to Gain Traction in Years to Come, States iGATE Research in Topical Research Study Available at MarketPublishers.com
21 Jul 2016 • by Natalie Aster
LONDON – The world’s breast cancer screening marketplace is poised to gain traction through to 2021. The key forces giving a boost to the market growth include the increasing incidence rates of breast cancer worldwide, an upsurge in government incentives and support, rising ageing female population, surging knowledge of early diagnosis of breast cancer, and technology developments. Nevertheless, factors like controversies pertaining to mastography and sociocultural barriers will likely inhibit the expansion of the sector in the forthcoming years.
Geography-wise, the USA is deemed to be the biggest market for screening for breast cancer. Germany and China are the 2nd and 3rd largest markets and are in close competition with each other to capture the largest slice of the pie. The UK was the 4th biggest breast cancer screening market as of 2015, with Italy following after..
With respect to breast cancer screening population, the nations like the USA, Japan, China, the UK and Germany account for the maximum share of the marketplace. In 2015, these 5 countries together grabbed more than 60% share of the overall breast cancer screening population. Italy, Spain, France, Brazil, India and South Korea are the other leading contributors to the breast cancer screening population globally.
Topical market research report “Breast Cancer Screening (Mammography, MRI and Ultrasound) Market and Population Forecast to 2021 - Global Analysis” created by iGATE Research offers an extensive analysis of the market globally with a special focus on the 31 key nations.
The study examines the breast cancer mammography, ultrasound screening and MRI sectors with respect to volume and value. For each country discusses, the report gives insights into the breast cancer screening population, breast cancer mammography screening population and breast cancer MRI and ultrasound screening population including an analysis of the market plus detailed forecasts. The research publication canvasses the markets for breast cancer mammography screening, MRI screening and ultrasound screening, as well as gives detailed projections of each marketplace. Furthermore, a comprehensive assessment of the major market drivers and challenges is also available in the report.
More new market studies can be found at iGATE Research page.